<DOC>
	<DOC>NCT00178971</DOC>
	<brief_summary>Examines cognitive functioning in patients with schizophrenia or schizoaffective disorder who have been treated with antipsychotic medications. Patients will be assigned to take active medication (Buspar)or placebo along with their prescribed antispycotic medication for six weeks. Patients' memory and problem-solving ability will be tested before and after medication.</brief_summary>
	<brief_title>Serotonin 1A Agonists and Cognition in Schizophrenia</brief_title>
	<detailed_description>Examines cognitive functioning in patients with schizophrenia or schizoaffective disorder who have been treated with olanzapine or risperidone for at least three months randomized to receive adjunctive treatment with a 5-HT1A agonist (buspirone, 15-30 mg/day)or placebo.</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Buspirone</mesh_term>
	<criteria>Subjects must meet all of the following criteria to be eligible for participation in the current research study. 1. Subjects will be males and females between 1865 years of age; 2. Subjects will have a definite diagnosis by DSMIV criteria for Schizophrenia or Schizoaffective Disorder; 3. The subjects or their legal guardian must sign the informed consent; 4. Subjects currently being treated with olanzapine or risperidone for a duration of at least 3 months 1. Subjects who are pregnant or lactating 2. Subjects who have brain damage and/or neurological disorders 3. Subjects who have current substance dependence 4. Subjects unable to provide informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>